Author

R. Anders

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1

Frequent Co-Authors

A. Cameron· 1 shared A. Girgis· 1 shared A. Gurakar· 1 shared A. Hernandez· 1 shared A. L. Huff· 1 shared A. Ogurtsova· 1 shared A. R. Ahmadi· 1 shared B. Gao· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Cameron

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade

D. H. Shu, W. J. Ho, L. T. Kagohara, A. Girgis, S. M. Shin, L. Danilova, J. W. Lee, D. N. Sidiropoulos, S. Mitchell, K. Munjal, K. Howe, K. J. Bendinelli, H. Qi, G. Mo, J. Montagne, , M. Yarchoan

This study examines TLS in HCC treated with neoadjuvant immunotherapy, finding TLS correlate with better outcomes and show distinct morphological and functional features in tumor regression.

bioRxiv · Oct 16, 2023 · PreprintImmunology

Discovery and characterization of cross-reactive intrahepatic antibodies in severe alcoholic hepatitis

A. R. Ahmadi, G. Song, T. Gao, J. Ma, X. Han, M.-W. Hu, A. Cameron, R. N. Wesson, B. Philosophe, S. Ottmann, E. King, A. Gurakar, L. Qi, B. Peiffer, J. Burdick, , Z. Sun

This study identifies cross-reactive intrahepatic antibodies in severe alcoholic hepatitis that target both bacterial antigens and human proteins, suggesting a role in disease pathogenesis.

bioRxiv · Feb 23, 2023Pathology